Civic AI
Procurement intelligence
Federal contract award
TO DEVELOP AN INTRAMUSCULAR INACTIVATED WHOLE VIRUS VACCINE FROM EARLY PRODUCT SELECTION THROUGH A PHASE I CLINICAL TRIAL TO INDUCE PROTECTION AGAINST EV D68 INDUCED AFM.
INTRAVACC B.V. · Department of Health and Human Services
- Value
- $10,006,906
- Start
- Sep 1, 2020
- End
- May 31, 2026
- Action date
- Mar 11, 2026
- PIID
- 75N93020C00037
- Status
- completed
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- —
- Award type
- DEFINITIVE CONTRACT
Description
TO DEVELOP AN INTRAMUSCULAR INACTIVATED WHOLE VIRUS VACCINE FROM EARLY PRODUCT SELECTION THROUGH A PHASE I CLINICAL TRIAL TO INDUCE PROTECTION AGAINST EV D68 INDUCED AFM.
Need modifications, related awards, and vendor peers? Open the full award workspace.